Kawasaki disease and familial hypercholesterolemia: Their potential synergistical impact on coronary arterial vascular health and viewpoints

Elsevier

Available online 27 November 2025

Journal of Clinical LipidologyAuthor links open overlay panel, , Section snippetsDeclaration of generative AI and AI-assisted technologies in the writing process

Generative artificial intelligence (ChatGPT) was used solely for grammatical checks during the writing process.

CRediT authorship contribution statement

Daisuke Matsubara: Writing – original draft, Conceptualization. Mitsuru Seki: Writing – review & editing, Supervision. Kazuhiko Kotani: Writing – review & editing, Supervision.

Acknowledgments

DM wrote the manuscript. MS and KK edited the manuscript from the perspectives of a Kawasaki disease specialist and a lipidology specialist, respectively. All the authors have read and approved the final version of this manuscript.

References (6)J. West et al.Multiple coronary artery aneurysms in a young patient with Kawasaki disease and heterozygous familial hypercholesterolemia: a case study

J Clin Lipidol

(2025)

Y. Nakamura et al.Epidemiology of Kawasaki disease in Japan in 2021-2022: results of the 27th nationwide survey

Pediatr Int

(2025)

R. Fukazawa et al.JCS/JSCS 2020 guideline on diagnosis and management of cardiovascular sequelae in Kawasaki disease

Circ J

(2020)

There are more references available in the full text version of this article.

View full text

© 2025 National Lipid Association. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.

Comments (0)

No login
gif